Genentech, Inc. - Company Profile and SWOT Analysis

May 2026 | 38 pages | ID: GE87827910FEN
MarketLine

US$ 175.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Summary

Genentech, Inc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

Genentech, Inc. (Genentech), a subsidiary of Roche Holding AG, discovers, develops, manufactures, and commercialization medications for serious and life-threatening illnesses. It provides drugs across various therapeutic areas, including oncology, neurology, infectious diseases, immunology, ophthalmology, metabolism, primary care, and specialty care. Additionally, Genentech offers patient support services such as co-pay programs, health insurance assistance, and independent co-pay support, among others. Its products primarily cater to patients with complex health issues within the US healthcare market. Operates a manufacturing facility located in the US. Genentech is headquartered in South San Francisco, California, the US.

Scope
  • Detailed information on Genentech, Inc. required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Genentech, Inc. in the form of a SWOT analysis
  • An in-depth view of the business model of Genentech, Inc. including a breakdown and examination of key business segments
  • Intelligence on Genentech, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
  • News about Genentech, Inc., such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
  • Gain understanding of Genentech, Inc. and the factors that influence its strategies.
  • Track strategic initiatives of the company and latest corporate news and actions.
  • Assess Genentech, Inc. as a prospective partner, vendor or supplier.
  • Support sales activities by understanding your customers' businesses better.
  • Stay up to date on Genentech, Inc.'s business structure, strategy and prospects.
Table of Contents
Company Snapshot
Genentech, Inc.: Company Overview
Genentech, Inc.: Overview and Key Facts
Genentech, Inc.: Overview
Genentech, Inc.: Key Facts
Genentech, Inc.: Key Employees
Genentech, Inc.: Major Products and Services
Genentech, Inc.: Key Competitors
Genentech, Inc.: Company Analysis
Genentech, Inc.: Business Description
Genentech, Inc.: SWOT Analysis
Genentech, Inc.: SWOT Overview
Genentech, Inc.: Strengths
Genentech, Inc.: Weaknesses
Genentech, Inc.: Opportunities
Genentech, Inc.: Threats
Genentech, Inc.: Corporate Financial Deals Activity
Genentech, Inc.: Financial Deals Overview
Genentech, Inc.: Targets and Partners
Genentech, Inc.: Top Deals 2022 - 2026YTD*
Genentech, Inc.: Advisors
Genentech, Inc.: Top Legal Advisors
Genentech, Inc.: Top Financial Advisors
Genentech, Inc.: Mergers and Acquisitions
Genentech, Inc.: Partnership
Genentech, Inc.: Recent Developments
Genentech, Inc.: News and Events Summary
Genentech, Inc.: Business Expansion
Genentech, Inc.: Corporate Governance
Genentech, Inc.: Financial Deals
Genentech, Inc.: Market Developments
Genentech, Inc.: Research & Development
Genentech, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine
LIST OF TABLES

Table 1: Genentech, Inc.: Key Facts
Table 2: Genentech, Inc.: Key Employees
Table 3: Genentech, Inc.: Key Competitors
Table 4: Genentech, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 5: Genentech, Inc.: Deal Activity by Deal Type - Volume (2022 - YTD*2026)
Table 6: Genentech, Inc.: M&A Average Deal Size - Value (US$m)
Table 7: Genentech, Inc.: Targets and Partners
Table 8: Genentech, Inc.: Top Deals 2022 - 2026YTD*
Table 9: Genentech, Inc.: Legal Advisor Ranking by Value (US$m)
Table 10: Genentech, Inc.: Financial Advisor Ranking by Value (US$m)
Table 11: Genentech, Inc.: M&A Volume and Value Trend (2022 - YTD*2026)
Table 12: Genentech, Inc.: Partnership Volume and Value Trend (2022 - YTD*2026)
Table 13: Genentech, Inc.: Partnership Trend by Deal Type (2022 - YTD*2026)
Table 14: Genentech, Inc.: News and Events Summary
Table 15: Genentech, Inc.: Business Expansion
Table 16: Genentech, Inc.: Corporate Governance
Table 17: Genentech, Inc.: Financial Deals
Table 18: Genentech, Inc.: Market Developments
Table 19: Genentech, Inc.: Research & Development
Table 20: Genentech, Inc.: Strategy and Operations
LIST OF FIGURES

Figure 1: Genentech, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Genentech, Inc.: Deal Activity by Deal Type - Volume (2022 - YTD*2026)
Figure 3: Genentech, Inc.: M&A Average Deal Size - Value (US$m)
Figure 4: Genentech, Inc.: M&A Volume and Value Trend (2022 - YTD*2026)
Figure 5: Genentech, Inc.: Partnership Volume and Value Trend (2022 - YTD*2026)
Figure 6: Genentech, Inc.: Partnership Trend by Deal Type (2022 - YTD*2026)


More Publications